1-9 of 9
Gerald Schrenk, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bispecific Antibodies with Native Human IgG Structure As Mimetics for FVIII Activity

Sabine Knappe, PhD, Nicolas Fischer, Patrice Robert Douillard, Rudolf Hartmann, PhD, Gerald Schrenk, PhD, Ulla Ravn, Giovanni Magistrelli, Franck Gueneau, Gerard Didelot, Krzysztof Masternak, Marie Kosco-Vilbois, Friedrich Scheiflinger, PhD, Michael Dockal, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1083.
https://doi.org/10.1182/blood.V130.Suppl_1.1083.1083
Published: 2017
Journal Articles

A Bispecific Antibody Lacks Measurability in Routine Coagulation Assays and Comparability to Factor VIII

Rudolf Hartmann, PhD, Tjerk Feenstra, MSc, Sabine Knappe, PhD, Gerald Schrenk, PhD, Friedrich Scheiflinger, PhD, Michael Dockal, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1080.
https://doi.org/10.1182/blood.V130.Suppl_1.1080.1080
Published: 2017
Journal Articles

Development of BAX 826, a Polysialylated Full-Length rFVIII with Significantly Improved PK Properties

Peter L. Turecek, PhD, Juergen Siekmann, PhD, Artur Mitterer, PhD, Michael Graninger, PhD, Gerald Schrenk, PhD, Peter Matthiessen, PhD, Hanspeter Rottensteiner, PhD, Werner Hoellriegl, DVM, Marietta Putz, MS, Hans Peter Schwarz, MD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2015) 126 (23): 3536.
https://doi.org/10.1182/blood.V126.23.3536.3536
Published: 2015
Journal Articles

Recombinant VWF Promotes Platelet Adhesion Under Shear Stress Dependent on Its Multimer Size

Gerald Schrenk, PhD, Jutta Schreiner, Herbert Gritsch, Peter L Turecek, PhD, Michael Dockal, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2014) 124 (21): 1442.
https://doi.org/10.1182/blood.V124.21.1442.1442
Published: 2014
Journal Articles

Impact of Factor IXa Content On Function, Safety and Efficacy of Recombinant Factor IX Products.

Wilfried Auer, PhD, Hanspeter Rottensteiner, PhD, Gerald Schrenk, PhD, Werner Hoellriegl, PhD, Alexandra Schiviz, DVM, Friedrich Scheiflinger, PhD, Hans Peter Schwarz, MD, Peter L Turecek, PhD, Eva-Maria Muchitsch, PhD
Journal: Blood
Blood (2012) 120 (21): 2233.
https://doi.org/10.1182/blood.V120.21.2233.2233
Published: 2012
Journal Articles

Functional Characterization of Baxter's Recombinant Human ADAMTS13 Drug Candidate.

Hanspeter Rottensteiner, PhD, Barbara Plaimauer, PhD, Gerald Schrenk, PhD, Michaela Schmidt, Bernadette Gruber, Jutta Schreiner, Peter L Turecek, PhD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2012) 120 (21): 2235.
https://doi.org/10.1182/blood.V120.21.2235.2235
Published: 2012
Journal Articles

Structural Characterization of BAX 855, a PEGylated Recombinant FVIII

Martin Kaliwoda, PhD, Michael Graninger, PhD, Peter Matthiessen, PhD, Gerald Schrenk, PhD, Peter L Turecek, PhD, Artur Mitterer, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD
Journal: Blood
Blood (2011) 118 (21): 4356.
https://doi.org/10.1182/blood.V118.21.4356.4356
Published: 2011
Journal Articles

Functional Characterization of BAX 855, a PEGylated Recombinant FVIII

Gerald Schrenk, PhD, Katalin Varadi, PhD, Herbert Gritsch, Hanspeter Rottensteiner, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Peter L Turecek, PhD
Journal: Blood
Blood (2011) 118 (21): 4359.
https://doi.org/10.1182/blood.V118.21.4359.4359
Published: 2011
Journal Articles

Binding of FVIII to Recombinant VWF

Gerald Schrenk, PhD, Katalin Varadi, PhD, Hanspeter Rottensteiner, PhD, Hartmut J. Ehrlich, MD, Friedrich Scheiflinger, PhD, Peter Turecek, PhD
Journal: Blood
Blood (2010) 116 (21): 1408.
https://doi.org/10.1182/blood.V116.21.1408.1408
Published: 2010